2.Prime Medicine, a biotech firm in Cambridge, Massachusetts, has already begun clinical trials of its drug PM359 for the treatment of chronic granulomatous disease—a life-threatening condition that affects the blood's ability to destroy infections.
马萨诸塞州剑桥市的生物科技公司 Prime Medicine 已开始对其药物 PM359 进行临床试验,该药物用于治疗慢性肉芽肿病——一种影响血液消灭感染能力的危及生命的疾病。机翻
「人 Science and technology」评价该例句:好评差评指正